GSK plc (GLAXF)
Develops and sells vaccines and medicines to treat cancer, respiratory diseases, infections, and other conditions worldwide.
$27.00+0.02%Healthcare
StockGlow Score
Leaning Bullish
BearishBullish
1 year ago+42.0%
The outlook
GSK is trading at $27, positioned solidly above both its 50- and 200-day moving averages and sitting roughly two-thirds of the way up its 52-week range. The stock carries a trailing P/E of 14.3 with analyst coverage leaning bullish overall. Price momentum appears steady rather than sharp in either direction.
What’s behind the score
Price trendAbove its 50- & 200-day averages
52-week range67% of the way from its 52-week low to high
Market cap
$108.15B
52-wk high
$31.48
52-wk low
$17.72
50-day avg
$25.61
200-day avg
$25.46
Trailing P/E
14.3